Sustained benefit at 2 years for covered stents versus bare-metal stents in long SFA lesions: the VIASTAR trial

J Lammer, T Zeller, KA Hausegger, PJ Schaefer… - Cardiovascular and …, 2015 - Springer
… At 24-month, this trial in PAD patients with long femoropopliteal lesions demonstrated a
significantly improved primary patency rate for heparin-bonded covered stents compared to BMS…

[HTML][HTML] Midterm outcome of femoral artery stenting and factors affecting patency

JS Yu, KM Park, YS Jeon, SG Cho… - Vascular Specialist …, 2015 - ncbi.nlm.nih.gov
SFA can achieve initial technical success rates of >95% with a low risk of complications [1].
Recent data suggest that stents may also improve the durability of SFASFA lesions in Korea. …

Loss of bifurcation patency after cross-over stenting of ostial lesions in superficial femoral artery: possible causes, prevention and reintervention

J Junhao, C Bin, D Zhihui, S Yun… - Chinese Medical …, 2014 - journals.lww.com
… ostial lesions in SFA, distal CFA and jailed ostial SFA stenting have significantly higher rate
of bifurcation patency loss than non-jailed ostial SFA … Surgical repair has more favorable and …

New stents for SFA

E Minar, M Schillinger - Journal of Cardiovascular Surgery, 2009 - search.proquest.com
… in length allow that more difficult and complex lesions can be treated … Future concepts to
further improve longterm patency after … These properties led to better patency rates compared to …

[PDF][PDF] Innovative technologies for SFA occlusions: drug coated balloons in SFA lesions

E Minar, M Schillinger - Journal of Cardiovascular Surgery, 2012 - researchgate.net
… antiproliferative drug at the site of injury has become one of the … lesions investigating the
efficacy of paclitaxel release by DCB, and all demonstrated significantly improved patency rates

Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN. PACT SFA

…, MR Jaff, IN. PACT SFA Trial Investigators - Journal of the American …, 2015 - jacc.org
… for longer lesions (>18 cm) and more complex lesion subsets… lesions should be made aware
that restenosis rates following … better patency and reduce the need for repeat procedures. …

Present and future of endovascular SFA treatment: stents, stent-grafts, drug coated balloons and drug coated stents

M Bosiers, K Deloose, J Verbist… - Journal of …, 2008 - search.proquest.com
… The use of drug-coated balloons could improve SFA patency rates for an enhanced PTA …
products, we can successfully start treating longer and more complex lesions and consider …

[HTML][HTML] Superficial femoral artery occlusion reduces aortofemoral bypass graft patency

A Tanaka, HK Sandhu, A Perlick, CC Miller III… - European Journal of …, 2019 - Elsevier
… occluded superficial femoral artery did not improve patency and increased early mortality. …
at the time of aortofemoral bypass; DU = disease untreated patients whose SFA lesion was not …

2-Year results of paclitaxel-coated balloons for long femoropopliteal artery disease: evidence from the SFA-Long study

A Micari, R Nerla, G Vadalà, F Castriota… - JACC: Cardiovascular …, 2017 - jacc.org
patency rate at 24 months, defined as freedom from the combined endpoints of clinically
driven target lesion … We previously reported good outcomes for PCBs in long lesions at 12 …

[HTML][HTML] Efficacy of Viabahn® in the treatment of severe superficial femoral artery lesions: which factors influence long-term patency?

YS Alimi, Z Hakam, O Hartung, M Boufi… - European Journal of …, 2008 - Elsevier
… treatment indications to more severe SFA occlusive lesions.9, 11 The results of the
present study confirm that 3-years primary and secondary SFA patency rates after Viabahn ® …